Which medications in the drug class Glycopeptides are used in the treatment of Meningitis?

Updated: Jul 16, 2019
  • Author: Rodrigo Hasbun, MD, MPH; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print


Vancomycin inhibits bacterial cell wall synthesis by blocking glycopeptide polymerization. It is indicated for many infections caused by gram-positive bacteria.


Vancomycin is a glycopeptide antibiotic that is active against staphylococci, streptococci, and other gram-positive bacteria. It exerts antibacterial activity by inhibiting biosynthesis of peptidoglycan and is the drug of choice for highly penicillin-resistant and ceftriaxone-resistant S pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA). It is a component of empiric first-line therapy for meningitis associated with central nervous system (CNS) shunts.

Because of poor CSF penetration, a higher dose of vancomycin is required for meningitis than for other infections. In patients with renal impairment, the dose is adjusted on the basis of the creatinine clearance.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!